Suppr超能文献

4-吗啉乙磺酸(MES)对脆弱拟杆菌金属β-内酰胺酶的意外抑制作用:分辨率为1.85埃的晶体学研究

Unanticipated inhibition of the metallo-beta-lactamase from Bacteroides fragilis by 4-morpholineethanesulfonic acid (MES): a crystallographic study at 1.85-A resolution.

作者信息

Fitzgerald P M, Wu J K, Toney J H

机构信息

Department of Biochemistry, Merck Research Laboratories, Rahway, New Jersey 07065, USA.

出版信息

Biochemistry. 1998 May 12;37(19):6791-800. doi: 10.1021/bi9730339.

Abstract

As part of a structure-aided effort to design clinically useful inhibitors of metallo-beta-lactamases, the X-ray crystal structure of a complex between the metallo-beta-lactamase from Bacteroides fragilis and 4-morpholinoethanesulfonic acid (MES) has been determined and a model for the structure has been refined to a crystallographic R-factor of 0.151 for data between 10.0- and 1.85-A resolution. Although the binding of MES was an adventitious result of the use of MES as a buffer in the crystallization mixture, MES was subsequently shown to be a competitive inhibitor of the enzyme, with a Ki of 23 +/- 5 mM. MES binds in the same fashion to both of the molecules in the crystallographic asymmetric unit; both direct and solvent-mediated hydrogen bonds to the protein and to the binuclear zinc cluster are observed, involving the oxygens of the sulfonic acid group and the nitrogen of the morpholino ring. In addition, there are hydrophobic interactions between the morpholino ring and residues in the flexible beta-strand of the enzyme between residues 26 and 36. Comparison of this structure with the previously reported unliganded structures of the same enzyme [Concha, N. O., Rasmussen, B. A., Bush, K., and Herzberg, O. (1996) Structure 4, 823-836; Carfi, A., Duée, E., Paul-Soto, R., Galleni, M., Frère, J. -M., and Dideberg, O. (1998) Acta Crystallogr. D54, 47-57] reveals that although the overall conservation of structure in the three different crystal lattices is very high, binding of MES is correlated with a significant change in the conformation of this beta-strand. The flexibility of this beta-strand will be an important consideration in the design of inhibitors of the metallo-beta-lactamases.

摘要

作为设计临床上有用的金属β-内酰胺酶抑制剂的结构辅助研究的一部分,已确定脆弱拟杆菌金属β-内酰胺酶与4-吗啉代乙磺酸(MES)复合物的X射线晶体结构,并将该结构模型精修至10.0至1.85 Å分辨率数据的晶体学R因子为0.151。尽管MES的结合是在结晶混合物中使用MES作为缓冲剂的偶然结果,但MES随后被证明是该酶的竞争性抑制剂,其抑制常数Ki为23±5 mM。MES以相同方式结合到晶体学不对称单元中的两个分子上;观察到与蛋白质和双核锌簇的直接和溶剂介导的氢键,涉及磺酸基团的氧和吗啉环的氮。此外,吗啉环与该酶26至36位残基的柔性β链中的残基之间存在疏水相互作用。将该结构与先前报道的同一酶的无配体结构[Concha, N. O., Rasmussen, B. A., Bush, K., and Herzberg, O. (1996) Structure 4, 823 - 836; Carfi, A., Duée, E., Paul - Soto, R., Galleni, M., Frère, J. - M., and Dideberg, O. (1998) Acta Crystallogr. D54, 47 - 57]进行比较,结果显示,尽管三种不同晶格中的整体结构保守性非常高,但MES的结合与该β链构象的显著变化相关。该β链的柔性将是设计金属β-内酰胺酶抑制剂时的一个重要考虑因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验